Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.

Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D'Haese PC, Evenepoel P.

PLoS One. 2017 May 11;12(5):e0176411. doi: 10.1371/journal.pone.0176411. eCollection 2017.

2.

Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.

Evenepoel P, Behets GJ, Viaene L, D'Haese PC.

Kidney Int. 2017 Feb;91(2):469-476. doi: 10.1016/j.kint.2016.10.008. Epub 2016 Dec 18.

PMID:
27998642
3.

Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.

Evenepoel P, Claes K, Viaene L, Bammens B, Meijers B, Naesens M, Sprangers B, Kuypers D.

Transplantation. 2016 Oct;100(10):2188-93. doi: 10.1097/TP.0000000000001311.

PMID:
27379556
4.

Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients.

Evenepoel P, Meijers BK, Bammens B, Viaene L, Claes K, Sprangers B, Naesens M, Hoekstra T, Schlieper G, Vanderschueren D, Kuypers D.

Nephrol Dial Transplant. 2016 Sep;31(9):1508-14. doi: 10.1093/ndt/gfv414. Epub 2016 Jan 31.

PMID:
26908778
5.

Inflammation and the bone-vascular axis in end-stage renal disease.

Viaene L, Behets GJ, Heye S, Claes K, Monbaliu D, Pirenne J, D'Haese PC, Evenepoel P.

Osteoporos Int. 2016 Feb;27(2):489-97. doi: 10.1007/s00198-015-3233-8. Epub 2015 Aug 21.

PMID:
26294291
6.

Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function.

Viaene L, Meijers BK, Vanrenterghem Y, Evenepoel P.

Perit Dial Int. 2015 Jul-Aug;35(4):492. doi: 10.3747/pdi.2015.00095. No abstract available.

7.

Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.

Poesen R, Viaene L, Verbeke K, Augustijns P, Bammens B, Claes K, Kuypers D, Evenepoel P, Meijers B.

BMC Nephrol. 2014 Jun 9;15:87. doi: 10.1186/1471-2369-15-87.

8.

Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotype.

Viaene L, Thijs L, Jin Y, Liu Y, Gu Y, Meijers B, Claes K, Staessen J, Evenepoel P.

PLoS One. 2014 May 21;9(5):e79682. doi: 10.1371/journal.pone.0079682. eCollection 2014.

9.

Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Viaene L, Meijers BK, Bammens B, Vanrenterghem Y, Evenepoel P.

Perit Dial Int. 2014 Jan-Feb;34(1):71-8. doi: 10.3747/pdi.2012.00276. Epub 2013 Oct 31. Erratum in: Perit Dial Int. 2015 Jul-Aug;35(4):492.

10.

Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.

Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B, Naesens M, Vanrenterghem Y, Kuypers D, Evenepoel P, Meijers B.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1508-14. doi: 10.2215/CJN.00300113. Epub 2013 Jun 27.

11.

Sclerostin: Another vascular calcification inhibitor?

Claes KJ, Viaene L, Heye S, Meijers B, d'Haese P, Evenepoel P.

J Clin Endocrinol Metab. 2013 Aug;98(8):3221-8. doi: 10.1210/jc.2013-1521. Epub 2013 Jun 20.

PMID:
23788689
12.

Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?

Viaene L, Behets GJ, Claes K, Meijers B, Blocki F, Brandenburg V, Evenepoel P, D'Haese PC.

Nephrol Dial Transplant. 2013 Dec;28(12):3024-30. doi: 10.1093/ndt/gft039. Epub 2013 Apr 19.

PMID:
23605174
13.

Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.

Viaene L, Annaert P, de Loor H, Poesen R, Evenepoel P, Meijers B.

Biopharm Drug Dispos. 2013 Apr;34(3):165-75. doi: 10.1002/bdd.1834. Epub 2013 Jan 24.

PMID:
23300093
14.

Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes.

Viaene L, Evenepoel P, Meijers B, Vanderschueren D, Overbergh L, Mathieu C.

Am J Nephrol. 2012;36(6):497-508. doi: 10.1159/000345146. Epub 2012 Nov 16.

15.

Calcium balance in chronic kidney disease: walking the tightrope.

Evenepoel P, Viaene L, Meijers B.

Kidney Int. 2012 Jun;81(11):1057-9. doi: 10.1038/ki.2012.33.

16.

Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease.

Viaene L, Meijers BK, Vanrenterghem Y, Evenepoel P.

Am J Nephrol. 2012;35(5):434-41. doi: 10.1159/000338299. Epub 2012 Apr 23.

PMID:
22538635
17.

Daytime rhythm and treatment-related fluctuations of serum phosphorus concentration in dialysis patients.

Viaene L, Meijers B, Vanrenterghem Y, Evenepoel P.

Am J Nephrol. 2012;35(3):242-8. doi: 10.1159/000336308. Epub 2012 Feb 18.

PMID:
22353750
18.

PTH, FGF23, and calcium: it takes three to tango?

Evenepoel P, Viaene L, Meijers B.

Kidney Int. 2011 Dec;80(12):1377. doi: 10.1038/ki.2011.350. No abstract available.

19.

Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients.

Viaene L, Bammens B, Meijers BK, Vanrenterghem Y, Vanderschueren D, Evenepoel P.

Nephrol Dial Transplant. 2012 May;27(5):2017-22. doi: 10.1093/ndt/gfr596. Epub 2011 Oct 24.

PMID:
22025115
20.

Targeting FGF23 and phosphorus in CKD, do not forget calcium.

Evenepoel P, Viaene L, Meijers BK.

Nephrol Dial Transplant. 2011 May;26(5):1749-50; author reply 1750. doi: 10.1093/ndt/gfr040. Epub 2011 Mar 3. No abstract available.

PMID:
21372258
21.

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

Evenepoel P, Meijers B, Viaene L, Bammens B, Claes K, Kuypers D, Vanderschueren D, Vanrenterghem Y.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1268-76. doi: 10.2215/CJN.08241109. Epub 2010 May 6.

22.

p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.

Meijers BK, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K, Kuypers D, Vanrenterghem Y, Evenepoel P.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1182-9. doi: 10.2215/CJN.07971109. Epub 2010 Apr 29.

23.

Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism.

Viaene L, Evenepoel P, Bammens B, Claes K, Kuypers D, Vanrenterghem Y.

Nephron Clin Pract. 2008;110(2):c80-5. doi: 10.1159/000151722. Epub 2008 Sep 1.

PMID:
18758187
24.

Frans De Schryver: forty years of photochemistry and photophysics.

Boens N, De Feyter S, Hofkens J, Viaene L, Van der Auweraer M.

Chemphyschem. 2005 Nov 11;6(11):2215-7. No abstract available.

PMID:
16273573
25.
26.

Direct proof of electron transfer in a rigid first generation triphenyl amine core dendrimer substituted with a peryleneimide acceptor.

Lor M, Jordens S, De Belder G, Schweitzer G, Fron E, Viaene L, Cotlet M, Weil T, Müllen K, Verhoeven JW, Van der Auweraer M, De Schryver FC.

Photochem Photobiol Sci. 2003 May;2(5):501-10.

PMID:
12803072
27.

Photoinduced electron transfer in a rigid first generation triphenylamine core dendrimer substituted with a peryleneimide acceptor.

Lor M, Thielemans J, Viaene L, Cotlet M, Hofkens J, Weil T, Hampel C, Müllen K, Verhoeven JW, Van Der Auweraer M, De Schryver FC.

J Am Chem Soc. 2002 Aug 21;124(33):9918-25.

PMID:
12175254

Supplemental Content

Loading ...
Support Center